20 Sep 2017 | 3:49 PM
 

Plethico Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532739 | NSE Symbol: PLETHICO
8.25
-0.10
(-1.19 %)
13 Jun 2016 | 03:41 PM
Change company
  • Open (Rs)
    8.31
  • Prev. close (Rs.)
    8.35
  • High (Rs.)
    8.31
  • Low (Rs.)
    7.94
  • 52W H (Rs.)
    0.00
  • 52W L (Rs.)
    0.00
  • Volume (Rs.)
    10351
  • MCap (Rs in Cr.)
    28.11
No Data Available
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
32.49
Operating Margin (%)
13.67
Gross Profit Margin (%)
10.56
Net Profit Margin (%)
5.27
Total Debt/Equity
0.42
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
100.00

News

20 Sep 2017 - 11:43:00-Divi’s Laboratories said that all the previous observations by US drug regulator regarding Uni...
20 Sep 2017 - 11:40:00-Shares of Divi's Laboratories jumped over 6 per cent on the Bombay Stock Exchange after the drug...
20 Sep 2017 - 11:14:00-Caplin Point Laboratories said that it has received approval from the U.S...
20 Sep 2017 - 11:03:00-Leading pharma major Strides Shasun has that it has received approval from the USFDA for Omega-3-Aci...

Announcements

25-Jul-2016
Plethico Pharmaceuti - Shareholding for the Period Ended June 30 2016
22-Jul-2016
Plethico Pharmaceuti - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended Ju
10-May-2016
Plethico Pharmaceuti - Resignation of Director
21-Apr-2016
Plethico Pharmaceuti - Shareholding for the Period Ended March 31 2016
20-Apr-2016
Plethico Pharmaceuti - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended Ma

Religare Research

19 Sep 2017 | 10:00 AM
The Indian rupee fell to a four-week low against the dollar, as state-run lenders bought the greenba...
19 Sep 2017 | 09:17 AM
• Gold dipped as equities and dollar surged ahead of Fed meeting • Oil prices steadied, held near re...
19 Sep 2017 | 07:00 AM
We suggest refraining from aggressive positions amid mixed signals and preferring hedged positions u...
18 Sep 2017 | 07:10 PM
Gold prices fell as investors shrugged off a rise in geopolitical uncertainty that followed after No...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

       
Promotors57.75%
Mutual Funds/UTI0.00%
FI/Banks16.71%
Insurance16.71%
FII2.70%
Government0.00%
Others4.61%

Peer Group

Company Intraday Graph
 Kovai Medical Center and Hospital Ltd.
1,100.00(-2.65)
11816
 Merck Ltd.
1,090.20(-0.41)
3302
 Neuland Laboratories Ltd.
1,051.10(-0.23)
3578
 AstraZeneca Pharma India Ltd.
949.60(-0.94)
3274

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Plethico Pharmaceuticals Ltd.0.21-2.39-3.72
NIFTY(S&P CNX)386.80483.601,014.30
BSE SENSEX1,141.661,088.942,881.77
BSE 500695.23802.981,650.30

Corporate Details

Key Personal
No Data Available
Key Address
Registered Office
A B Road Manglia,Indore,Madhya Pradesh

Tel:0731-2806271 2806275, Fax:0731-2806271

pledge@plethico.com
http://www.plethico.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :C 101 247 Park ? L.B.S. Marg Vikhroli (West)

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Plethico Pharmaceuticals Ltd. that will help you decide whether to buy, sell or hold Plethico Pharmaceuticals Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Plethico Pharmaceuticals Ltd.